Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Dose Escalation Study of Bradanicline in Refractory Chronic Cough

ClinicalTrials.gov ID: NCT03622216

Public ClinicalTrials.gov record NCT03622216. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 27, 2026, 12:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Dose Escalation Study to Assess the Efficacy and Safety of Bradanicline in Subjects With Refractory Chronic Cough

Study identification

NCT ID
NCT03622216
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Attenua, Inc.
Industry
Enrollment
46 participants

Conditions and interventions

Conditions

Interventions

  • Bradanicline Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 4, 2018
Primary completion
May 6, 2019
Completion
May 21, 2019
Last update posted
Jun 19, 2019

2018 – 2019

United States locations

U.S. sites
17
U.S. states
10
U.S. cities
15
Facility City State ZIP Site status
BioSolutions Clinical Research Center La Mesa California 91942
Allergy & Asthma Associates of Southern California Mission Viejo California 92691
Asthma and Allergy Associates Colorado Springs Colorado 80907
Storms Clinical Research Institute Colorado Springs Colorado 80907
Colorado Allergy and Asthma Center Denver Colorado 80230
Center for Cough Largo Florida 33872
Florida Pulmonary Research Institute Winter Park Florida 32789
Clinical Research Institute Plymouth Minnesota 55441
Mayo Clinic, Pulmonary Clinic Research Unit Rochester Minnesota 55905
Atlantic Research Center, LLC Ocean Township New Jersey 07712
Clinical Research of Gastonia Gastonia North Carolina 20854
National Allergy and Asthma Research North Charleston South Carolina 29420
AARA Research Center Dallas Texas 75231
Pharmaceutical Research and Consulting, Inc. Dallas Texas 75231
Diagnostics Research Group San Antonio Texas 78229
Bellingham Asthma Allergy and Immunology Clinic Bellingham Washington 98225
Allery Asthma & Sinus Center Greenfield Wisconsin 53228

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03622216, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 19, 2019 · Synced Jun 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03622216 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →